In the reduction group , 10 patients ( 62.5 % ) did not demonstrate continuous D receptor blockade above 65 % ( ie , < 65 % at trough ) after dose reduction ; furthermore , 7 patients ( 43.8 % ) did not achieve a threshold of 65 % occupancy even at peak .